Cite
MLA Citation
S.H. Ou et al.. “MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study.” European journal of cancer, vol. 174, n.d., pp. S122–. http://access.bl.uk/ark:/81055/vdc_100169168811.0x00003c